Contract 75F40120D00032
We Pharma, Inc. · Department Of Health And Human Services · September 29, 2020
We Pharma, Inc. was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 29, 2020 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $9.50 million.
Contract details
- PIID
- 75F40120D00032
- Award type
- —
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 29, 2020
Description
THE PURPOSE AND OBJECTIVES OF THIS REQUIREMENT IS TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES.
Modification timeline
-
September 29, 2020Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Phlow Corp. | Department Of Health And Human Services | July 2, 2026 | $696.67M |
| Sri International | Department Of Health And Human Services | July 2, 2026 | $0 |
| Pfizer Inc | Department Of Health And Human Services | June 29, 2026 | $1.12B |
| Kymanox Corp | Department Of Health And Human Services | June 25, 2026 | $0 |
| Mckesson Specialty Distribution Llc | Department Of Health And Human Services | June 24, 2026 | $203.93M |
| Mriglobal | Department Of Health And Human Services | June 24, 2026 | $514.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40120D00032?
Contract 75F40120D00032 is a federal contract awarded to We Pharma, Inc. by Department Of Health And Human Services on September 29, 2020 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75F40120D00032?
We Pharma, Inc. won contract 75F40120D00032 from Department Of Health And Human Services.
How much is contract 75F40120D00032 worth?
Contract 75F40120D00032 has obligated $0 to date but carries a potential ceiling of $9.50 million if fully funded and all options are exercised.